Search research articles
Contact Us
Filters
Showing results (21-30 of 72) with videos related to
Page
of 8
Sort By:
International Journal of Dermatology
|
October 10, 2025
Improvement in Patient-Reported Emotional Symptoms and Activity Limitations due to Hair Loss in Patients With Alopecia Areata Treated With Ritlecitinib: Additional Analyses From ALLEGRO-2b/3
Ernest H Law, Bintu Sherif, Arash Mostaghimi, et al.
The Journal of Allergy and Clinical Immunology
|
November 1, 2020
The emerging role of Janus kinase inhibitors in the treatment of autoimmune and inflammatory diseases
William Damsky, Danielle Peterson, Julie Ramseier, et al.
Dermatology and Therapy
|
November 22, 2023
Clinical Benefits of Baricitinib Therapy According to Scalp Hair Regrowth in Patients with Severe Alopecia Areata
Maryanne M Senna, Ohsang Kwon, Bianca M Piraccini, et al.
BMC Oral Health
|
June 13, 2026
Deep learning models for the detection of dental-findings and tooth-types using video data
Julia Michelin, Ayesha Nooruddin, Aamna Khalid, et al.
JID Innovations : Skin Science From Molecules to Population Health
|
October 24, 2022
Safety and Efficacy of Ritlecitinib and Brepocitinib in Alopecia Areata: Results from the Crossover Open-Label Extension of the ALLEGRO Phase 2a Trial
Brett King, Emma Guttman-Yassky, Elena Peeva, et al.
Dermatology and Therapy
|
July 20, 2022
A Qualitative Study to Develop and Evaluate the Content Validity of the Vitiligo Patient Priority Outcome (ViPPO) Measures
Helen Kitchen, Kavita Gandhi, Chloe Carmichael, et al.
The British Journal of Dermatology
|
April 3, 2025
Understanding Eyebrow and Eyelash Involvement in Patients with Alopecia Areata and Responsiveness to Treatment with Baricitinib
Arash Mostaghimi, Brittany Craiglow, Brett King, et al.
Nature Reviews. Disease Primers
|
November 6, 2025
Alopecia areata
Benjamin Ungar, Yael Renert-Yuval, Ncoza C Dlova, et al.
Journal of the American Academy of Dermatology
|
November 28, 2025
Maintenance of long-term efficacy with continuous baricitinib treatment in patients with severe alopecia areata: 3-year results from BRAVE-AA1 and BRAVE-AA2
Maryanne Senna, Arash Mostaghimi, Rodney Sinclair, et al.
Advances in Therapy
|
July 22, 2021
Alopecia Areata Treatment Patterns, Healthcare Resource Utilization, and Comorbidities in the US Population Using Insurance Claims
Maryanne Senna, Justin Ko, Antonella Tosti, et al.
Page
of 8
Search research articles
Search
Showing results (21-30 of 72) with videos related to
Sort By:
Page
of 8
International Journal of Dermatology
|
October 10, 2025
Improvement in Patient-Reported Emotional Symptoms and Activity Limitations due to Hair Loss in Patients With Alopecia Areata Treated With Ritlecitinib: Additional Analyses From ALLEGRO-2b/3
Ernest H Law, Bintu Sherif, Arash Mostaghimi, et al.
The Journal of Allergy and Clinical Immunology
|
November 1, 2020
The emerging role of Janus kinase inhibitors in the treatment of autoimmune and inflammatory diseases
William Damsky, Danielle Peterson, Julie Ramseier, et al.
Dermatology and Therapy
|
November 22, 2023
Clinical Benefits of Baricitinib Therapy According to Scalp Hair Regrowth in Patients with Severe Alopecia Areata
Maryanne M Senna, Ohsang Kwon, Bianca M Piraccini, et al.
BMC Oral Health
|
June 13, 2026
Deep learning models for the detection of dental-findings and tooth-types using video data
Julia Michelin, Ayesha Nooruddin, Aamna Khalid, et al.
JID Innovations : Skin Science From Molecules to Population Health
|
October 24, 2022
Safety and Efficacy of Ritlecitinib and Brepocitinib in Alopecia Areata: Results from the Crossover Open-Label Extension of the ALLEGRO Phase 2a Trial
Brett King, Emma Guttman-Yassky, Elena Peeva, et al.
Dermatology and Therapy
|
July 20, 2022
A Qualitative Study to Develop and Evaluate the Content Validity of the Vitiligo Patient Priority Outcome (ViPPO) Measures
Helen Kitchen, Kavita Gandhi, Chloe Carmichael, et al.
The British Journal of Dermatology
|
April 3, 2025
Understanding Eyebrow and Eyelash Involvement in Patients with Alopecia Areata and Responsiveness to Treatment with Baricitinib
Arash Mostaghimi, Brittany Craiglow, Brett King, et al.
Nature Reviews. Disease Primers
|
November 6, 2025
Alopecia areata
Benjamin Ungar, Yael Renert-Yuval, Ncoza C Dlova, et al.
Journal of the American Academy of Dermatology
|
November 28, 2025
Maintenance of long-term efficacy with continuous baricitinib treatment in patients with severe alopecia areata: 3-year results from BRAVE-AA1 and BRAVE-AA2
Maryanne Senna, Arash Mostaghimi, Rodney Sinclair, et al.
Advances in Therapy
|
July 22, 2021
Alopecia Areata Treatment Patterns, Healthcare Resource Utilization, and Comorbidities in the US Population Using Insurance Claims
Maryanne Senna, Justin Ko, Antonella Tosti, et al.
Page
of 8